Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052782

CEO and Chairman sold 2,500 shares at an average $50.15 ($125,372)

  • CEO and Chairman acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Exercise or conversion : show line 1 in the form +1,900 $0.33 $627 1,780,080 D
2020-09-29 Sale : show line 2 in the form −1,900 $50.18 $95,342 1,778,180 D
2020-10-01 Exercise or conversion : show line 3 in the form +600 $0.33 $198 1,778,780 D
2020-10-01 Sale : show line 4 in the form −600 $50.05 $30,030 1,778,180 D
Open-market sales · 2,500 sh · avg $50.15 · $125,372

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-09-29 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,900 192,740 D
2020-10-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −600 192,140 D
Loading xslF345X03/doc4.xml…